After the London Whale trading fiasco, many investors have sworn off allocating any of their funds to JPMorgan Chase (NYSE: JPM ) and often point to lack of trust as their reason.
Motley Fool writers Ilan Moscovitz and John Reeves recently laid out why they wouldn't touch JPMorgan's stock.
However, in classic Fool fashion, health-care analyst Max Macaluso sought to hear the other side of the story and sat down with banking analyst David Hanson. In this video, David acknowledges the hesitation to trust the JPMorgan management team but highlights the enormously profitable enterprise and its bright future.
With big finance firms still trading at deep discounts to their historic norms, investors everywhere are wondering if this is the new normal, or if finance stocks are a screaming buy today. The answer depends on the company, so to help figure out whether JPMorgan is a buy today, check out The Motley Fool's premium research report on the company. Click here now for instant access!